Found: 1733
Select item for more details and to access through your institution.
Assessing 1-year sodium-glucose co-transporter-2 inhibitor tolerance in older adults.
- Published in:
- Age & Ageing, 2024, v. 53, n. 10, p. 1, doi. 10.1093/ageing/afae237
- By:
- Publication type:
- Article
The effects of sodium-glucose cotransporters type 2 inhibitors on glycemic and extraglycemic laboratory parameters.
- Published in:
- International Journal of Diabetes in Developing Countries, 2024, v. 44, n. 4, p. 737, doi. 10.1007/s13410-023-01307-z
- By:
- Publication type:
- Article
SGLT2 Inhibitor Prescribing in Cardiovascular-Kidney-Metabolic Syndrome.
- Published in:
- 2024
- By:
- Publication type:
- Letter
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art.
- Published in:
- American Journal of Cardiovascular Drugs, 2024, v. 24, n. 6, p. 707, doi. 10.1007/s40256-024-00673-1
- By:
- Publication type:
- Article
Role of SGLT2 inhibitors in improving cardiac functions (on Echocardiography) in patients having Diabetes Mellitus and ischemic heart disease.
- Published in:
- Journal of University Medical & Dental College, 2024, v. 15, n. 3, p. 884, doi. 10.37723/jumdc.v15i3.942
- By:
- Publication type:
- Article
Journal club: Type 2 diabetes -- reframing the first stage of care.
- Published in:
- Journal of Diabetes Nursing, 2024, v. 28, n. 3, p. 1
- By:
- Publication type:
- Article
Novel antidiabetes drugs improve composite renal outcomes.
- Published in:
- Journal of Diabetes Nursing, 2024, v. 28, n. 2, p. 1
- Publication type:
- Article
Journal club: Ideas for diabetes care -- something borrowed, something blue.
- Published in:
- Journal of Diabetes Nursing, 2023, v. 27, n. 5, p. 1
- By:
- Publication type:
- Article
Latest news: Tirzepatide for type 2 diabetes; cardio-diabetes clinics; and cardiorenal biomarkers in DKD: Stay abreast of the latest news that could impact diabetes nursing.
- Published in:
- Journal of Diabetes Nursing, 2023, v. 27, n. 5, p. 1
- Publication type:
- Article
Making the most of SGLT2 inhibitors in primary care.
- Published in:
- Journal of Diabetes Nursing, 2023, v. 27, n. 4, p. 1
- By:
- Publication type:
- Article
Evaluating the renoprotective effectiveness of sodium-glucose co-transporter 2 inhibitor therapy in patients with chronic kidney disease: a prospective study.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2024, v. 81, n. 1, p. 39, doi. 10.2298/VSP230805061K
- By:
- Publication type:
- Article
Circulating level of β-aminoisobutyric acid (BAIBA), a novel myokine-like molecule, is inversely associated with fat mass in patients with heart failure.
- Published in:
- Heart & Vessels, 2024, v. 39, n. 1, p. 35, doi. 10.1007/s00380-023-02308-y
- By:
- Publication type:
- Article
Glucose-dependent diuresis in relation to improvements in renal-tubular markers of sodium-glucose cotransporter-2 inhibitors in hospitalized heart failure patients with diabetes.
- Published in:
- Heart & Vessels, 2021, v. 36, n. 7, p. 978, doi. 10.1007/s00380-020-01768-w
- By:
- Publication type:
- Article
Mechanisms and prediction of short-term natriuretic effect of sodium-glucose cotransporter 2 inhibitor in heart failure patients coexisting type 2 diabetes mellitus.
- Published in:
- Heart & Vessels, 2020, v. 35, n. 9, p. 1218, doi. 10.1007/s00380-020-01597-x
- By:
- Publication type:
- Article
SGLT2 inhibitors and AMPK: The road to cellular housekeeping?
- Published in:
- Cell Biochemistry & Function, 2024, v. 42, n. 1, p. 1, doi. 10.1002/cbf.3922
- By:
- Publication type:
- Article
SGLT2 inhibitors and autophagy in diabetes.
- Published in:
- Cell Biochemistry & Function, 2023, v. 41, n. 4, p. 392, doi. 10.1002/cbf.3792
- By:
- Publication type:
- Article
SGLT2 inhibitor as a potential therapeutic approach in hyperthyroidism-induced cardiopulmonary injury in rats.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2024, v. 476, n. 7, p. 1125, doi. 10.1007/s00424-024-02967-4
- By:
- Publication type:
- Article
Association between sodium–glucose cotransporter-2 (SGLT2) inhibitors and macular degeneration in patients with diabetes: a nationwide population-based study in Taiwan.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 9, p. 1161, doi. 10.1007/s00592-024-02303-3
- By:
- Publication type:
- Article
Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 6, p. 755, doi. 10.1007/s00592-024-02252-x
- By:
- Publication type:
- Article
Assessing early tubular protective effects of SGLT2 inhibitor empagliflozin against type 2 diabetes mellitus using functional magnetic resonance imaging.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 4, p. 473, doi. 10.1007/s00592-023-02220-x
- By:
- Publication type:
- Article
Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 12, p. 1651, doi. 10.1007/s00592-023-02154-4
- By:
- Publication type:
- Article
Dose-dependent renoprotection efficacy of sglt2 inhibitors in type 2 diabetes: systematic review and network meta-analysis.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 10, p. 1311, doi. 10.1007/s00592-023-02126-8
- By:
- Publication type:
- Article
AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 9, p. 1257, doi. 10.1007/s00592-023-02115-x
- By:
- Publication type:
- Article
Comparing sodium-glucose cotransporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on new-onset depression: a propensity score-matched study in Hong Kong.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 7, p. 917, doi. 10.1007/s00592-023-02063-6
- By:
- Publication type:
- Article
Baseline eGFR, albuminuria and renal outcomes in patients with SGLT2 inhibitor treatment: an updated meta-analysis.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 3, p. 435, doi. 10.1007/s00592-022-02022-7
- By:
- Publication type:
- Article
Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 3, p. 325, doi. 10.1007/s00592-022-01989-7
- By:
- Publication type:
- Article
Effect of sodium–glucose cotransporter 2 inhibitors on insulin resistance; a systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 2, p. 191, doi. 10.1007/s00592-022-01981-1
- By:
- Publication type:
- Article
Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis.
- Published in:
- Acta Diabetologica, 2022, v. 59, n. 6, p. 783, doi. 10.1007/s00592-022-01866-3
- By:
- Publication type:
- Article
Tandem positive action of SGLT2 inhibitors and ARNI in patients with heart failure.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Sodium–glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 7, p. 869, doi. 10.1007/s00592-021-01686-x
- By:
- Publication type:
- Article
Evaluation of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Prescribing Patterns in Heart Failure Patients at Hospital Discharge.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 6, p. 1318, doi. 10.1177/08971900241256772
- By:
- Publication type:
- Article
Impact of American Diabetes Association 2022 Guidelines on Prescribing Rates of Sodium-Glucose Cotransporter-2 Inhibitors in Ambulatory Care Organization Patients With Type 2 Diabetes.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 6, p. 1267, doi. 10.1177/08971900241247658
- By:
- Publication type:
- Article
Risk of Urinary Infections in Veterans on Empagliflozin With Concurrent Catheter Use.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 5, p. 1127, doi. 10.1177/08971900241229107
- By:
- Publication type:
- Article
Impact of Inpatient Initiation of SGLT2 Inhibitors on Diuretic Requirements in Patients With Heart Failure.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 3, p. 683, doi. 10.1177/08971900231159739
- By:
- Publication type:
- Article
Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 2, p. 495, doi. 10.1177/08971900221142686
- By:
- Publication type:
- Article
Comparison of A1c Reduction, Weight Loss, and Changes in Insulin Requirements With Addition of GLP-1 Agonists vs SGLT-2 Inhibitors in Patients Using Multiple Daily Insulin Injections.
- Published in:
- Journal of Pharmacy Practice, 2024, v. 37, n. 2, p. 311, doi. 10.1177/08971900221134174
- By:
- Publication type:
- Article
Evaluation of Loop Diuretic Dosing Following Sodium-Glucose Cotransporter 2 Inhibitor Initiation in Patients With Heart Failure.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 6, p. 1330, doi. 10.1177/08971900221116187
- By:
- Publication type:
- Article
How Low Can You Go? Safety and Efficacy of Sodium-Glucose Cotransporter Inhibitors in Decreased Renal Function.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 2, p. 429, doi. 10.1177/08971900211039707
- By:
- Publication type:
- Article
Pharmacotherapy Considerations in Heart Failure with Mildly-Reduced Ejection Fraction.
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 1, p. 155, doi. 10.1177/08971900211027315
- By:
- Publication type:
- Article
Long-Term Mortality and SGLT2 Inhibitors in Type 2 Diabetes with and without Renal Impairment: An Observational Cohort Study.
- Published in:
- Medical Principles & Practice, 2024, v. 33, n. 3, p. 251, doi. 10.1159/000537850
- By:
- Publication type:
- Article
QSAR Studies of Sodium/Glucose Co-Transporter 2 Inhibitors as Potent Anti-Diabetic Drug Agents.
- Published in:
- Theoretical Foundations of Chemical Engineering, 2023, v. 57, p. S51, doi. 10.1134/S004057952307014X
- By:
- Publication type:
- Article
The changes of oxidative stress markers and Vitamin E in patients with diabetes using SGLT2 inhibitors.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes: Protocol for a Kidney End Points Real-world Study (COMBi-KID Study).
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 7, p. 1, doi. 10.2196/34206
- By:
- Publication type:
- Article
From Clinical Trial Evidence to Clinical Guidelines: Perspectives on REWIND from Clinicians in the Gulf and Levant Region.
- Published in:
- Dubai Diabetes & Endocrinology Journal, 2023, v. 29, n. 3/4, p. 153, doi. 10.1159/000534713
- By:
- Publication type:
- Article
Real-World Evaluation of Demographics, Treatment Pattern, and Economic Burden of Heart Failure and Kidney Disease in Type 2 Diabetes Mellitus Patient Population in Dubai, United Arab Emirates.
- Published in:
- Dubai Diabetes & Endocrinology Journal, 2023, v. 29, n. 1, p. 42, doi. 10.1159/000530467
- By:
- Publication type:
- Article
Гепатоцентричний підхід до досягнення компенсації цукрового діабету 2-го типу в осіб з неалкогольним стеатогепатитом.
- Published in:
- International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal, 2024, v. 20, n. 5, p. 375, doi. 10.22141/2224-0721.20.5.2024.1423
- By:
- Publication type:
- Article
Комплексний підхід в лікуванні ожиріння: ефективність застосування агоніста глюкагоноподібного пептиду 1 та дозованого фізичного навантаження.
- Published in:
- International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal, 2022, v. 18, n. 3, p. 145, doi. 10.22141/2224-0721.18.3.2022.1161
- By:
- Publication type:
- Article
Позитивний ефект вітаміну D на зниження маси тіла у пацієнтів з ожирінням на тлі лікування глюкагоноподібним пептидом 1 та модифікації способу життя.
- Published in:
- International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal, 2022, v. 18, n. 5, p. 278, doi. 10.22141/2224-0721.18.5.2022.1186
- By:
- Publication type:
- Article
Цукровий діабет і хронічна серцева недостатність.
- Published in:
- International Journal of Endocrinology / Mìžnarodnij Endokrinologìčnij Žurnal, 2022, v. 18, n. 1, p. 57, doi. 10.22141/2224-0721.18.1.2022.1146
- By:
- Publication type:
- Article
Inhibitory SGLT2 (3. část) - glukuronidace jako hlavní cesta biotransformace gliflozinů.
- Published in:
- Remedia, 2022, v. 32, n. 3, p. 312
- By:
- Publication type:
- Article